Prevalence of the impaired glucose metabolism and its association with risk factors for coronary artery disease in women with gestational diabetes

Diabetes Research and Clinical Practice

Volumn 79, Issue 3, 2008, Pages 433-437

  Rivero, Katia ^a   Portal, Vera Lúcia ^b   Vieira, Matias ^b   Behle, Ivo ^a,b  

^a FUC   (Brazil)

^b INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

Author keywords

Coronary artery disease; Gestational diabetes; Glucose; Metabolism; Risk factors

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; PREGNANCY DIABETES MELLITUS; PREVALENCE; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BRAZIL; CHOLESTEROL, HDL; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; PREGNANCY; PREVALENCE; RISK FACTORS;

EID: 39449096613     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.10.015     Document Type: Article

References (32)

1. Nesto R.W. Correlation between cardiovascular disease and diabetes mellitus: current concepts. Am. J. Med. 116 5A (2004) 11S-22S
2. Silva M.R.G., Calderon I.M.P., Gonçalves L.C., Aragon F.F., Padovani C.R., and Pimenta W.P. Ocorrência de diabetes melito em mulheres com hiperglicemia em gestação prévia. Rev Saúde Pública 37 3 (2003) 345-350
3. Lauenborg J., Hansen T., Jensen D.M., Vestergaard H., Molsted-Petersen L., Hornnes P., et al. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 27 5 (2004) 1194-1199
4. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339 4 (1998) 229-234
5. Howard B.V., Best L.G., Galloway J.M., Howard W.J., Jones K., Lee E.T., et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 29 (2006) 391-397
6. Hanzal D., and Ducharme A. Noninvasive assessment of coronary artery disease in diabetic patients: the role of stress echocardiography. Can. J. Cardiol. 22 Suppl. A (2006) 26-33
7. Raza J.A., and Movahed A. Current concepts of cardiovarcular diseases in diabetes mellitus. Int. J. Cardiol. 89 (2003) 123-134
8. Rosenberg D.E., Jabbour S.A., and Goldstein B.J. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment. Diabetes Obes. Metab. 7 6 (2005) 642-653
9. Ridker P.M. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am. J. Cardiol. 92 Suppl. (2003) 17KK-22KK
10. Ridker P.M. C-reactive protein, inflammation, and cardiovascular disease. N. Engl. J. Med. 352 (2005) 1293-1304
11. Schmidt M.I., Duncan B.B., Sharret A.R., Lindberg G., Savage P.J., Offembacher S., et al. Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 353 9165 (1999) 1649-1652
12. Narayan K.M., Gregg E.W., Fagot-Campagna A., Engelgau M.M., and Vinicor F. Diabetes-a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res. Clin. Pract. 50 Suppl. 2 (2000) S77-S84
13. Schaan B.D., and Portal V.L. Fisiopatologia da doença cardiovascular no diabetes. Rev da Sociedade de Cardiologia do RS XIII 3 (2004) 1-3
14. I. Behle, O sistema Hospital-Dia na assistência à gestantes com intolerância aos hidratos de carbono e diabetes mellitus, Thesis, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, 1996.
15. O'Sullivan J.B., Charles D., Mahan C.M., and Dandrow R.V. Gestational diabetes and perinatal mortality rate. Am. J. Obst. Gynecol. 116 (1973) 901-904
16. a. Reunião do Grupo de Trabalho em Diabetes e Gravidez. Arq Bras Endocrinol Metab 46 5 (2002) 574-581
17. American Diabetes Association. Clinical practice recommendations. Gestational diabetes. Diabetes Care 27 Suppl. 1 (2004) S88-S90
18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Clinical practice recommendations. Diabetes Care 27 Suppl. 1 (2004) S5-S10
19. IV Diretrizes Brasileiras de Hipertensão Arterial (IV Brazilian Guidelines in arterial hypertension). Arq. Bras. Cardiol. 82 Suppl. 4 (2004) 7-22
20. Coustan D.R. Gestational diabetes. In: Harris M.I., Cowie C.C., Stern M.P., Boyko E.J., Reiber G.E., and Benett P.H. (Eds). Diabetes in America. second ed. (1995), National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases 703-717
21. Cheung N.W., and Helmink D. Gestational diabetes: the significance of persistent fasting hyperglycemia for the subsequent development of diabetes mellitus. J. Diabetes Complications 20 1 (2006) 21-25
22. Kim C., Newton K.M., and Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25 10 (2002) 1862-1868
23. Rosenberg T.J., Garbers S., Lipkind H., and Chiasson M.A. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am. J. Public Health 95 9 (2005) 1545-1551
24. Clark Jr. C.M., Qui C., Amerman B., Porter B., Fineberg N., Aldasouigi S., et al. Gestational diabetes: should it be added to the syndrome of insulin resistance?. Diabetes Care 20 (1997) 867-871
25. III Brazilian Guidelines on Dyslipidemias and Guideline of Atherosclerosis Prevention from Atherosclerosis Department of Sociedade Brasileira de Cardiologia. Arq. Bras. Cardiol. 77 Suppl. 3 (2001) 1-48
26. Meyers-Seifer C.H., and Vohr B.R. Lipid levels in former gestational diabetic mothers. Diabetes Care 19 (1996) 1351-1356
27. Ridker P.M., Buring J.E., Shih J., Matias M., and Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98 8 (1998) 731-733
28. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107 (2003) 499-511
29. Weinstein A.R., Sesso H.D., Lee I.M., Cook N.R., Manson J.E., Buring J.E., et al. Relationship of physical activity vs. body mass index with type 2 diabetes in women. JAMA 292 10 (2004) 1232-1234
30. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 1 (2003) 76-79
31. Schaan B.D., Harzheim E., and Gus I. Perfil de risco cardíaco no diabetes mellitus e na glicemia de jejum alterada. Rev Saúde Pública 38 4 (2004) 529-536
32. Osei K. Insulin resistance and systemic hypertension. Am. J. Cardiol. 84 (1999) 33j-36j